In recent years, GLP-1 receptor agonists, such as Novo Nordisk's Wegovy and Eli ... guidance to stop pharmacists distributing Rybelsus (Semaglutide) to new patients, due to supply issues.

In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...

Facing steep competition, Novo Nordisk has slashed the price for its weight loss drug Wegovy — temporarily, at least.

Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S ... which are both based on the same basic ingredient, semaglutide. At the peak, the company's market capitalization ...

Novo Nordisk warned the US government not to impose pharma-specific tariffs, but instead to tax illegal importers of ...

Semaglutide belongs to a group of drugs called GLP-1R agonists and has been shown to effectively reduce food intake and body weight. The drug is already well established as part of the treatment ...